COURTNEY BOUCKE: Open Payments
NPI 1831433119 · GRASS VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 6 payments from 6 companies in 2025. Trend: 2023 $162 · 2024 $667 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| ABBVIE INC. | 1 | $24 |
| Braintree Laboratories, Inc. | 1 | $23 |
Products named: Epclusa, ENTYVIO, REZDIFFRA, TREMFYA, SKYRIZI, SUTAB.
Industry payments across CA — which companies pay providers there.
